Overview
Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CELSIUS® has five beverage lines that each offer proprietary, functional, healthy-energy formulas clinically-proven to offer significant health benefits to its users. The five lines include, CELSIUS® Originals, CELSIUS HEAT™, CELSIUS® BCAA +Energy, CELSIUS® On-the-Go, and CELSIUS® Sweetened with Stevia. CELSIUS® has zero sugar, no preservatives, no aspartame, no high fructose corn syrup, and is non-GMO, with no artificial flavors or colors. The CELSIUS® line of products is Certified Kosher and Vegan. CELSIUS® is also soy and gluten-free and contains very little sodium. CELSIUS® is backed by six university studies that were published in peer-reviewed journals validating the unique benefits CELSIUS® provides. CELSIUS® is sold nationally at Target, CVS, Walmart, GNC, Vitamin Shoppe, 7-Eleven, Dick's Sporting Goods, The Fresh Market, Sprouts and other key regional retailers such as HEB, Publix, Winn-Dixie, Harris Teeter, Shaw's and Food Lion. It is also available on Amazon, at fitness clubs and in select micro-markets across the country.
AI+ Ask Fintel’s AI assistant about Celsius Holdings, Inc..
Thinking about good questions…
Basic Stats
The share price of Celsius Holdings, Inc. as of September 5, 2025 is $58.37 / share. This is a decrease of -7.17% from the prior week. The market cap (or net worth) of Celsius Holdings, Inc. as of September 5, 2025 is $15,049.84 MM.
The Factor Analysis chart (below right) shows a view of Celsius Holdings, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 15,049.84 MM |
| EV | 16,131.02 MM |
| Shares Out. | 257.77 MM |
| Earnings Date | |
| EPS (TTM) | 0.51 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.36 |
| Short Shares Avail. | 4.10 MM |
| Short Interest | 20.49 MM |
| Short Float | 10.36 % |
| Days to Cover | 4.12 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 82.28 % |
| Volatility (1 yr) | 0.63 |
| Beta | 0.50 |
| Sharpe Ratio (1 yr) | 1.23 |
| Sortino Ratio (1 yr) | 2.68 |
| PE Ratio | 114.23 |
| Price/Book | 7.20 |
| Price/TBV | -19.87 |
| Book/Market | 0.14 |
| EBIT/EV | 0.01 |
| EBIT(3yr avg)/EV | 0.01 |
| ROA | 0.08 |
| ROE | 0.11 |
| ROIC | 0.04 |
| CROIC | -0.10 |
| OCROIC | 0.08 |
| Implied Volatility | 41.35 % |
| Put/Call OI Ratio | 0.70 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Celsius Holdings, Inc. is $59.35. The forecasts range from a low of $32.84 to a high of $76.65. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Celsius Holdings, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-06 | B of A Securities | Neutral | Initiate | |
| 2022-12-06 | Credit Suisse | Neutral | Maintains | |
| 2022-10-11 | Wedbush | Neutral | Initiate | |
| 2022-08-11 | UBS | Buy | Maintains | |
| 2022-08-02 | Stifel | Buy | Maintains | |
| 2022-06-10 | Stifel | Buy | Maintains | |
| 2022-05-11 | Maxim Group | Hold | Buy | Upgrade |
| 2022-05-11 | Credit Suisse | Neutral | Maintains | |
| 2021-11-16 | Stifel | Buy | Initiate | |
| 2021-11-12 | Credit Suisse | Outperform | Neutral | Downgrade |
| 2021-11-12 | B. Riley Securities | Buy | Maintains | |
| 2021-09-16 | Jefferies | Buy | Initiate | |
| 2021-09-10 | Roth Capital | Buy | Maintains | |
| 2021-08-13 | Credit Suisse | Outperform | Maintains | |
| 2021-06-11 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2021-05-14 | Credit Suisse | Neutral | Maintains | |
| 2021-05-14 | B. Riley Securities | Buy | Maintains | |
| 2021-04-06 | Credit Suisse | Neutral | Initiate | |
| 2021-01-05 | Maxim Group | Buy | Hold | Downgrade |
| 2020-11-13 | Ladenburg Thalmann | Buy | Neutral | Downgrade |
| 2020-05-13 | B. Riley FBR | Buy | Maintains | |
| 2020-04-30 | Roth Capital | Buy | Initiate | |
| 2018-08-07 | B. Riley FBR | Buy | Buy | Maintains |
| 2018-02-01 | Maxim Group | Buy | Initiate | |
| 2017-08-16 | B. Riley FBR | Buy | Initiate | |
| 2023-02-06 | Wedbush | Neutral | Outperform | Upgrade |
| 2023-02-28 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2023-03-02 | UBS | Buy | Maintains | |
| 2023-03-02 | Credit Suisse | Outperform | Reiterate | |
| 2023-03-06 | Credit Suisse | Outperform | Reiterate | |
| 2023-04-26 | Piper Sandler | Overweight | Initiate | |
| 2023-05-23 | B of A Securities | Buy | Buy | Maintains |
| 2023-06-02 | UBS | Buy | Buy | Maintains |
| 2023-05-10 | Stifel | Buy | Buy | Maintains |
| 2023-05-10 | Wedbush | Outperform | Maintains | |
| 2023-05-10 | Piper Sandler | Overweight | Maintains | |
| 2023-05-10 | UBS | Buy | Maintains | |
| 2023-05-10 | B of A Securities | Neutral | Buy | Upgrade |
| 2023-06-05 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-06-07 | Stifel | Buy | Buy | Maintains |
| 2023-06-23 | Roth MKM | Buy | Buy | Maintains |
| 2023-06-23 | Stephens & Co. | Overweight | Initiate | |
| 2023-11-13 | Jefferies | Buy | Initiate | |
| 2023-07-19 | Maxim Group | Buy | Hold | Downgrade |
| 2023-10-23 | William Blair | Outperform | Initiate | |
| 2023-11-15 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-03-11 | Stifel | Buy | Buy | Maintains |
| 2023-07-11 | Stifel | Buy | Buy | Reiterate |
| 2023-08-29 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-09-15 | TD Cowen | Outperform | Initiate | |
| 2023-09-12 | B. Riley Securities | Buy | Buy | Maintains |
| 2023-06-22 | Wedbush | Outperform | Outperform | Maintains |
| 2024-05-03 | Wedbush | Outperform | Outperform | Reiterate |
| 2023-11-07 | Wedbush | Outperform | Outperform | Reiterate |
| 2023-08-09 | Stifel | Buy | Buy | Maintains |
| 2023-08-09 | Wedbush | Outperform | Outperform | Maintains |
| 2023-10-31 | Morgan Stanley | Equal-Weight | Initiate | |
| 2023-07-31 | Stifel | Buy | Buy | Maintains |
| 2023-11-08 | B. Riley Securities | Buy | Buy | Maintains |
| 2023-11-08 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-09-21 | Roth MKM | Buy | Buy | Maintains |
| 2023-08-03 | Wedbush | Outperform | Outperform | Reiterate |
| 2023-11-08 | Wedbush | Outperform | Outperform | Reiterate |
| 2024-05-02 | Stifel | Buy | Buy | Maintains |
| 2023-11-01 | Wedbush | Outperform | Outperform | Reiterate |
| 2023-10-02 | Roth MKM | Buy | Buy | Reiterate |
| 2023-11-28 | Morgan Stanley | Equal-Weight | Equal-Weight | Reiterate |
| 2023-12-04 | Stifel | Buy | Buy | Maintains |
| 2024-05-08 | Wedbush | Outperform | Outperform | Maintains |
| 2024-05-08 | UBS | Buy | Buy | Maintains |
| 2024-05-29 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-05-28 | Morgan Stanley | Equal-Weight | Equal-Weight | Reiterate |
| 2024-03-14 | Roth MKM | Buy | Buy | Maintains |
| 2024-03-13 | Jefferies | Buy | Buy | Maintains |
| 2024-01-19 | B of A Securities | Buy | Neutral | Downgrade |
| 2024-02-27 | Wedbush | Outperform | Outperform | Maintains |
| 2024-03-27 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-03-01 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-03-01 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-03-01 | UBS | Buy | Buy | Maintains |
| 2024-03-01 | Stifel | Buy | Buy | Maintains |
| 2024-02-02 | Maxim Group | Hold | Buy | Upgrade |
| 2024-02-16 | Stifel | Buy | Buy | Maintains |
| 2024-03-04 | Wedbush | Outperform | Outperform | Maintains |
| 2024-01-29 | Wedbush | Outperform | Outperform | Reiterate |
| 2024-06-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-06-12 | Wedbush | Outperform | Outperform | Maintains |
| 2024-06-12 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-06-12 | Stifel | Buy | Buy | Maintains |
| 2024-06-13 | Jefferies | Buy | Buy | Maintains |
| 2024-06-13 | TD Cowen | Buy | Buy | Maintains |
| 2024-07-10 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-07-09 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-09 | Stifel | Buy | Buy | Maintains |
| 2024-06-26 | Stifel | Buy | Buy | Maintains |
| 2024-06-17 | Roth MKM | Buy | Buy | Maintains |
| 2024-07-15 | TD Cowen | Buy | Buy | Maintains |
| 2024-06-25 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-06-25 | Truist Securities | Hold | Initiate | |
| 2024-06-24 | Exane BNP Paribas | Outperform | Initiate | |
| 2024-06-18 | Maxim Group | Buy | Buy | Maintains |
| 2024-12-12 | JP Morgan | Overweight | Initiate | |
| 2024-12-12 | Deutsche Bank | Hold | Initiate | |
| 2024-09-24 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-10-16 | Truist Securities | Hold | Hold | Maintains |
| 2025-01-23 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-08-09 | Truist Securities | Hold | Hold | Maintains |
| 2024-07-18 | Roth MKM | Buy | Buy | Maintains |
| 2024-10-21 | Ladenburg Thalmann | Neutral | Neutral | Maintains |
| 2024-08-07 | UBS | Buy | Buy | Maintains |
| 2024-08-07 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-07 | B. Riley Securities | Buy | Buy | Maintains |
| 2024-08-07 | Roth MKM | Buy | Buy | Maintains |
| 2024-08-07 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-09-27 | Roth MKM | Buy | Buy | Maintains |
| 2024-12-26 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-28 | Needham | Buy | Buy | Reiterate |
| 2024-12-18 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-22 | B. Riley Securities | Buy | Buy | Maintains |
| 2024-08-08 | B of A Securities | Neutral | Underperform | Downgrade |
| 2024-08-07 | TD Cowen | Buy | Buy | Maintains |
| 2025-03-27 | Ladenburg Thalmann | Neutral | Neutral | Maintains |
| 2024-07-22 | Jefferies | Buy | Buy | Maintains |
| 2024-09-05 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-09-05 | Stifel | Buy | Buy | Maintains |
| 2024-11-07 | Stifel | Buy | Buy | Maintains |
| 2024-11-07 | Roth MKM | Buy | Buy | Maintains |
| 2024-11-07 | UBS | Buy | Buy | Maintains |
| 2024-11-07 | B. Riley Securities | Buy | Buy | Maintains |
| 2025-01-06 | Needham | Buy | Buy | Reiterate |
| 2024-12-06 | Needham | Buy | Initiate | |
| 2025-02-25 | Needham | Buy | Buy | Maintains |
| 2025-01-16 | UBS | Buy | Buy | Maintains |
| 2025-02-21 | B. Riley Securities | Buy | Buy | Reiterate |
| 2025-02-21 | Roth MKM | Buy | Buy | Reiterate |
| 2024-09-06 | Truist Securities | Hold | Hold | Maintains |
| 2024-09-05 | Roth MKM | Buy | Buy | Maintains |
| 2024-09-05 | Jefferies | Buy | Buy | Maintains |
| 2024-09-05 | B of A Securities | Underperform | Underperform | Maintains |
| 2024-09-05 | Maxim Group | Buy | Buy | Maintains |
| 2025-06-12 | Stifel | Buy | Reiterate | |
| 2024-08-20 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-12-16 | Roth MKM | Buy | Buy | Maintains |
| 2025-08-08 | UBS | Buy | Buy | Maintains |
| 2025-08-08 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-08 | B. Riley Securities | Buy | Buy | Maintains |
| 2025-08-08 | Stifel | Buy | Buy | Maintains |
| 2025-04-17 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-11-04 | B. Riley Securities | Buy | Buy | Maintains |
| 2025-05-07 | Needham | Buy | Buy | Reiterate |
| 2025-05-29 | Needham | Buy | Buy | Reiterate |
| 2025-06-16 | TD Cowen | Hold | Buy | Upgrade |
| 2025-06-04 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-06-04 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-02-10 | Stifel | Buy | Buy | Maintains |
| 2025-05-15 | Needham | Buy | Buy | Maintains |
| 2025-04-09 | Needham | Buy | Buy | Maintains |
| 2025-04-17 | UBS | Buy | Buy | Maintains |
| 2025-07-17 | UBS | Buy | Buy | Maintains |
| 2025-07-10 | Needham | Buy | Buy | Maintains |
| 2025-06-26 | Roth Capital | Buy | Buy | Maintains |
| 2025-08-08 | Citigroup | Buy | Buy | Maintains |
| 2025-08-08 | Maxim Group | Buy | Buy | Maintains |
| 2025-05-02 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-09-05 | Needham | Buy | Buy | Maintains |
| 2025-06-06 | Truist Securities | Buy | Buy | Maintains |
| 2025-07-14 | Truist Securities | Buy | Buy | Maintains |
| 2025-07-31 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-07-23 | Citigroup | Buy | Initiate | |
| 2025-08-07 | Needham | Buy | Buy | Maintains |
| 2025-08-11 | Truist Securities | Buy | Buy | Maintains |
| 2025-08-08 | B of A Securities | Underperform | Underperform | Maintains |
| 2025-09-02 | B. Riley Securities | Buy | Buy | Maintains |
| 2025-09-02 | Roth Capital | Buy | Buy | Maintains |
| 2025-09-02 | UBS | Buy | Buy | Maintains |
| 2025-09-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-09-02 | Stifel | Buy | Buy | Maintains |
| 2025-09-02 | Mizuho | Outperform | Outperform | Maintains |
| 2025-07-29 | B. Riley Securities | Buy | Buy | Maintains |
| 2025-07-29 | Stifel | Buy | Buy | Maintains |
| 2025-09-03 | Jefferies | Buy | Buy | Maintains |
